Investigating the association of proton pump inhibitors with chronic kidney disease and its impact on clinical practice and future research: a review

被引:0
作者
Ejaz Cheema
机构
[1] University of Birmingham,Institute of clinical sciences
来源
Journal of Pharmaceutical Policy and Practice | / 12卷
关键词
Proton pump inhibitors; Chronic kidney disease; Clinical practice;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 82 条
  • [1] Heidelbaugh JJ(2012)Overutilization of proton-pump inhibitors: what the clinician needs to know Ther Adv Gastroenterol 5 219-232
  • [2] Kim AH(2015)Trends in prescription drug use among adults in the United States from 1999-2012 JAMA. 314 1818-1831
  • [3] Chang R(2016)Adverse effects associated with proton pump inhibitors JAMA Intern Med 176 172-174
  • [4] Walker PC(2016)Proton pump inhibitor prescribing patterns in the UK: a primary care database study Pharmacoepidemiol Drug Saf 25 1079-1087
  • [5] Kantor ED(2016)Global prevalence of chronic kidney disease – a systematic review and meta-analysis PLoS One 11 e0158765-246
  • [6] Rehm CD(2016)Proton pump inhibitor use and the risk of chronic kidney disease JAMA Intern Med 176 238-2827
  • [7] Haas JS(2016)Proton pump inhibitors are associated with increased risk of development of chronic kidney disease BMC Nephrol 17 112-68
  • [8] Chan AT(2017)Associations of proton-pump inhibitors and H2 receptor antagonists with chronic kidney disease: a meta-analysis Dig Dis Sci 62 2821-171
  • [9] Giovannucci EL(2018)Association of proton pump inhibitor use with renal outcomes in patients with coronary artery disease Kidney Res Clin Pract 37 59-710
  • [10] Schoenfeld AJ(2018)Using proton pump inhibitors correlates with an increased risk of chronic kidney disease: a nationwide database-derived case-controlled study Fam Pract 35 166-72